Stockscreener 앱 받기
0.854
3.74%
-0.0332
시간 외 거래:
.86
0.006
+0.70%
전일 마감가:
$0.8872
열려 있는:
$0.89
하루 거래량:
576.40K
Relative Volume:
0.45
시가총액:
$72.13M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.4798
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
+6.75%
1개월 성능:
+16.35%
6개월 성능:
-55.05%
1년 성능:
-80.98%
1일 변동 폭
$0.854
$0.9249
1주일 범위
$0.8111
$1.01
52주 변동 폭
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.854 | 74.93M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Is Sutro Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis Inside Free Real Profit Trade Plan Suggestions - Newser
Is Sutro Biopharma Inc. stock overvalued or undervaluedFree Stock Market Forecast Reports - jammulinksnews.com
Is Sutro Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis Inside200 Percent Profit Outlook - metal.it
Does Sutro Biopharma Inc. stock perform well during market downturnsAccelerated wealth expansion - jammulinksnews.com
How strong is Sutro Biopharma Inc. company’s balance sheetTriple-digit returns - jammulinksnews.com
What are the latest earnings results for Sutro Biopharma Inc.Explosive portfolio gains - jammulinksnews.com
What institutional investors are buying Sutro Biopharma Inc. stockUnstoppable investment returns - jammulinksnews.com
What are the technical indicators suggesting about Sutro Biopharma Inc.High-yield investments - jammulinksnews.com
What makes Sutro Biopharma Inc. stock price move sharplyGet timely alerts on market movers - jammulinksnews.com
Key External Factors That Drive Sutro Biopharma Inc. Stock Price MovementsMomentum Buy Alert - Newser
Why Sutro Biopharma Inc. stock attracts strong analyst attentionParabolic Move Ideas - Newser
What analysts say about Sutro Biopharma Inc. stockFree Capital Allocation Plans - PrintWeekIndia
Sutro Biopharma Inc. Stock Analysis and ForecastFree Capital Growth Strategies - Autocar Professional
How Sutro Biopharma Inc. stock reacts to Fed policy changesUnrivaled growth potential - jammulinksnews.com
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance
What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com
Sutro Biopharma partners with FDA to develop ADC reference materials By Investing.com - Investing.com South Africa
Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com Australia
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times
FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan
Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser
How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):